India focused: IPO, special situations, Stylus Holdings

Himanshu Dugar

Himanshu is a SEBI registered independent equity research analyst (SEBI Reg No. INH200009944, BSE Enlistment No. 5593). He has 11+ years of experience in buy-side equity research through his stints at CRISIL and Miras investments.
At CRISIL, he has conducted deep analysis in multiple sectors ranging from consumer discretionary to pharma/ chemicals as well as consumer staples.
At Miras Investments, his role was to analyse late-stage investment opportunities in India focusing on Pre-IPO and IPOs.

Stylus Holdings is a buy-side equity research firm. We offer bottom-up investment ideas as well as provide on demand equity research and portfolio tracking. Our bottom-up ideas range from IPO/QIPs to special situations; the underlying criteria is to identify market dislocations that can generate 20+% IRR with a reasonable safety margin.
As part of our research process, we do a deep dive into the fundamentals of the company, evaluate their competitive positioning and assess their valuation.

India focused: IPO, special situations

Edelweiss: Making the Right Moves | EAAA IPO by Q3FY27

Edelweiss: FY26 Earnings and SOTP Updates

Edelweiss Financial (EDEL IN): Attractive Valuations with Value Unlocking on the Anvil

Stylus Holdings

Stylus Holdings is a buy-side equity research firm. We offer bottom-up investment ideas as well as provide on demand equity research and portfolio tracking. 
At Stylus, our focus is to identify market dislocations that can generate 20+% IRR with a reasonable margin of safety. As part of our research process, we do a deep dive into the fundamentals of the company, evaluate their competitive positioning and assess their valuation.
Our investment team is led by Himanshu Dugar. Himanshu is a Chartered Accountant and a CFA charter holder. He has 10+ years of active experience in the stock market with stints at CRISIL Research, a S&P Global copmany and Miras Investments, a single family office based in Dubai.

Equity Research Firm

Equity Bottom-Up

Edelweiss Financial Services / Equity Bottom-Up

<ul>
<li>Edelweiss reported strong Q1 results, with healthy metrics across the board.</li>
<li>Sharp business velocity in General insurance and NBFC business suggests valuations can be revised upwards.</li>
<li>However, the Alternate Assets IPO and subsequent delivery in the NBFC business (MSME lending) can only trigger re-rating from here</li>
</ul>


Edelweiss reported strong Q1 results, with healthy metrics across the board.
Sharp business velocity in General insurance and NBFC business suggests valuations can be revised upwards.
However, the Alternate Assets IPO and subsequent delivery in the NBFC business (MSME lending) can only trigger re-rating from here


Edelweiss Financial Services

EDEL IN: 1Q 2027 and SOTP Refresh